Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy
Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy. // Journal of the American Society of Cytopathology. – URL: https://www.sciencedirect.com/science/article/pii/S2213294526002735?dgcid=rss_sd_all
Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy. Journal of the American Society of Cytopathology. https://www.sciencedirect.com/science/article/pii/S2213294526002735?dgcid=rss_sd_all
“Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy.” Journal of the American Society of Cytopathology.
@article{article31203,
title = {Biomarker Adequacy Across Bronchoscopic Sampling Modalities Without Rapid Onsite Evaluation (ROSE): Experience with Pre-Analytical Workflow for Fine Needle Aspiration, Transbronchial Biopsy, and Cryobiopsy},
journal = {Journal of the American Society of Cytopathology},
url = {https://www.sciencedirect.com/science/article/pii/S2213294526002735?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....